Clinical Trial Update: A Study to Compare How the Study Medicine (PF-07923568) is Processed in Participants With Different Levels of Loss of Liver Function to Healthy Participants. [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study compared how PF-07923568 is processed in participants with hepatic impairment versus healthy participants; results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Impairment
• Liver Diseases

Drugs mentioned

• PF-07923568

Snippet

Sponsor: Pfizer | Conditions: Liver Diseases, Hepatic Impairment | Phase 1 | Status: COMPLETED | Results posted: 2025-03-21